Related Experiment Video
Updated: Feb 11, 2026
![[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59739.jpg&w=3840&q=50)
[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst
Published on: May 21, 2019
β-Caryophyllene (BCP) ameliorates MPP+ induced cytotoxicity
Guifang Wang1, Weibin Ma1, Jingwei Du1
1Department of Neurology, Liaocheng People's Hospital, Liaocheng City, Shandong Province, 252000, China.
Beta-caryophyllene (BCP) shows neuroprotective effects against Parkinson's disease (PD) toxins. BCP treatment restored cell viability and reduced oxidative stress in neuronal cells, suggesting therapeutic potential for PD.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Parkinson's disease (PD) involves dopaminergic neuron death.
- MPP+ is a known neurotoxin that damages these neurons.
- Beta-caryophyllene (BCP) is a cannabinoid with known pharmacological properties.
Purpose of the Study:
- To investigate the neuroprotective effects of BCP against MPP+-induced toxicity in neuronal cells.
- To explore the mechanisms underlying BCP's potential therapeutic action in Parkinson's disease models.
Main Methods:
- Utilized SH-SY5Y cells exposed to MPP+ to model Parkinson's disease neurotoxicity.
- Assessed cell viability, lactate dehydrogenase (LDH) release, reactive oxygen species (ROS) generation, and mitochondrial membrane potential (MMP).
- Investigated the role of cannabinoid receptor type 2 (CB2R) and analyzed apoptosis-related proteins (Caspase-3, Bax, Bcl-2) and signaling pathways (HO-1, JNK).
Main Results:
- BCP treatment significantly restored cell viability reduced by MPP+.
- BCP suppressed MPP+-induced LDH release and ROS generation while restoring MMP.
- BCP demonstrated antioxidant effects via CB2R, inhibited apoptosis, and reduced HO-1 activation and JNK phosphorylation.
Conclusions:
- BCP exhibits significant neuroprotective effects against MPP+-induced toxicity in neuronal cells.
- These protective effects are mediated through antioxidant actions, apoptosis inhibition, and modulation of specific signaling pathways.
- BCP shows promise as a potential therapeutic agent for Parkinson's disease.
Related Concept Videos
TGF - β Signaling Pathway
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Antihypertensive Drugs: Types of β-Blockers
Heart Failure Drugs: β-Blockers

